Systematic Characterization of Clinically Actionable Antibody-Drug Targets Across Solid Tumors to Advance Precision Oncology
Crossref REST API · 学术索引收录 · 来源发布:Wed Nov 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 本站收录:Wed Nov 18 2026 15:09:25 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
Abstract The rapid expansion of antibody therapeutics is shifting the clinical bottleneck from drug availability to precise patient selection. We systematically characterize 87 clinically actionable tumor-associated antigens across solid tumors by integrating transcriptomic, proteomic, spatial, and single-cell profiles from more than 32,000 specimens to define expression prevalence, intratumoral h
以上为带出处的原文节选,完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。